BioShares Biotechnology Alpha and Beta Analysis

BioShares Biotechnology Clinical Trials -- USA Etf  

USD 30.6  0.75  2.51%

This module allows you to check different measures of market premium for BioShares Biotechnology Clinical Trials as well as systematic risk associated with investing in BioShares Biotechnology over a specified time horizon. Check also BioShares Biotechnology Backtesting, Portfolio Optimization, BioShares Biotechnology Correlation, BioShares Biotechnology Hype Analysis, BioShares Biotechnology Volatility, BioShares Biotechnology History and analyze BioShares Biotechnology Performance
 Time Horizon     30 Days    Login   to change
Symbol
Run Premiums

BioShares Biotechnology Market Premiums

α (average alpha)=0.97    β (beta)=2.26    
30 days against DJI
Risk Adjusted Performance  0.1341Jensen Alpha  1.02Total Risk Alpha  (0.36)Sortino Ratio  0.1717Treynor Ratio  (0.23)

BioShares Biotechnology expected buy-and-hold returns

   

BioShares Biotechnology Market Price Analysis

Price Series Summation
Price Series Division
Inverse Tangent Over Price Movement
Price Ceiling Movement
Aroon Oscillator
Balance Of Power
Bollinger Bands
Double Exponential Moving Average
Belt hold
Hanging Man

BioShares Biotechnology Return and Market Media

The median price of BioShares Biotechnology for the period between Mon, Dec 18, 2017 and Wed, Jan 17, 2018 is 28.73 with a coefficient of variation of 4.03. The daily time series for the period is distributed with a sample standard deviation of 1.16, arithmetic mean of 28.9, and mean deviation of 0.98. The Etf received some media coverage during the period.
Price Growth (%)  
      Timeline 
1
BioShares Biotechnology Clinical Trials Rises 2.51 percent f...01/17/2018